Related Experiment Video
Updated: Aug 19, 2025

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
A PMS2 non-canonical splicing site variant leads to aberrant splicing in a patient suspected for lynch syndrome
Ahmed Bouras1, Pierre Naibo2, Clémentine Legrand3
1Laboratory of constitutional genetics for frequent cancers HCL-CLB, Centre Leon Berard, 69008, Lyon, France. ahmed.bouras@lyon.unicancer.fr.
Abstract:
The PMS2 gene is one of the DNA mismatch repair genes (MMR) implicated in Lynch syndrome (LS). A subset of PMS2 pathogenic variants (PVs) are splice variants mostly affecting canonical GT/AG splicing sequences. However, the majority of the intronic variants outside canonical splice sites remained as variants of unknown significance, even though some of them would alter the splicing process. In this report, we describe the analysis of such an intronic variant (c.251-5T > C) detected in an 82-year-old patient diagnosed with endometrial cancer displaying microsatellite instability and the loss of PMS2 expression displayed. RNA analysis demonstrated that this variant lead to the complete exon 4 skipping, resulting in the synthesis of a truncated protein. This finding shows the relevance of functional RNA analysis in the non-canonical intronic variant assessment and the importance of systematic evaluation of MSI/loss of expression of MMR genes for LS screening in patients with endometrial cancers.
Insights
A PMS2 gene variant, previously unknown significance, caused exon skipping and a truncated protein in an endometrial cancer patient. This highlights the need for RNA analysis in Lynch syndrome screening.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Lynch syndrome (LS) is linked to DNA mismatch repair (MMR) gene variants, including PMS2.
- Many intronic PMS2 variants outside canonical splice sites are classified as variants of unknown significance.
- Assessing these variants is crucial for accurate LS diagnosis.
Observation:
- An intronic PMS2 variant (c.251-5T>C) was identified in an endometrial cancer patient with microsatellite instability and loss of PMS2 expression.
- RNA analysis was performed to investigate the functional impact of this intronic variant.
- The patient was 82 years old and diagnosed with endometrial cancer.
Findings:
- The intronic PMS2 variant (c.251-5T>C) caused complete skipping of exon 4.
- This exon skipping resulted in the synthesis of a truncated PMS2 protein.
- Functional RNA analysis revealed the pathogenic nature of a non-canonical intronic variant.
Implications:
- Functional RNA analysis is essential for assessing non-canonical intronic variants in MMR genes.
- Systematic evaluation of microsatellite instability (MSI) and MMR gene expression loss is important for LS screening in endometrial cancer patients.
- This study underscores the clinical relevance of investigating intronic variants for Lynch syndrome diagnosis.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Non-LTR Retrotransposons
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Abnormal Proliferation

